Slow Bull
The market, slowly. THURSDAY, 24 SEPTEMBER 2026
← All news
Markets

Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment of Hereditary Angioedema Transcript

1 source ·1 article ·Sep 8, 17:45 UTC Pharvaris N.V. Information Services

Covered by 1 outlet

Seekingalpha 1

All coverage · 1 article

Seeking Alpha ·Sep 8, 17:45 UTC

Pharvaris N.V. (PHVS) Discusses Topline Results of Chapter-3 Phase III Study on Deucrictibant for Prophylactic Treatment of Hereditary Angioedema Transcript